Patents-Review.com
🔗 Permalink
Assignee profile:

Moderna TX, Inc.

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

17

Last publication date:

2024-12-26

Patent Grants:

4

Last grant date:

2024-08-27

Top Inventors for applications by Moderna TX, Inc.

These are the the leading inventors for applications assigned to Moderna TX, Inc.:

Recent patent applications by Moderna TX, Inc.

Moderna TX, Inc. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-12-26
US20240425902A1
Chemistry; metallurgy

METHODS OF PURIFYING DNA FOR GENE SYNTHESIS

 #2 | 2024-11-21
US20240383940A1
Chemistry; metallurgy

SYNTHESIS OF TRINUCLEOTIDE AND TETRANUCLEOTIDE CAPS FOR MRNA PRODUCTION

 #3 | 2024-09-12
US20240299531A1
Human necessities

THERAPEUTIC USE OF SARS-COV-2 MRNA DOMAIN VACCINES

 #4 | 2024-07-25
US20240247239A1
Chemistry; metallurgy

POLYNUCLEOTIDES ENCODING ORNITHINE TRANSCARBAMYLASE FOR THE TREATMENT OF UREA CYCLE DISORDERS

 #5 | 2024-03-28
US20240100151A1
Human necessities

VARIANT STRAIN-BASED CORONAVIRUS VACCINES

 #6 | 2024-03-28
US20240100145A1
Human necessities

VLP ENTEROVIRAL VACCINES

 #7 | 2023-04-06
US20230108894A1
Human necessities

CORONAVIRUS RNA VACCINES

 #8 | 2022-11-03
US20220349006A1
Chemistry; metallurgy

CAP GUIDES AND METHODS OF USE THEREOF FOR RNA MAPPING

 #9 | 2022-08-04 ✅ Patent 12,070,495 granted on 2024-08-27
US20220241399A1
Human necessities

HIV RNA vaccines

 #10 | 2022-02-17 ✅ Patent 12,151,029 granted on 2024-11-26
US20220047518A1
Human necessities

PEG lipids and uses thereof

 #11 | 2020-08-13
US20200254086A1
Human necessities

EFFICACIOUS MRNA VACCINES

 #12 | 2020-07-02 ✅ Patent 11,285,222 granted on 2022-03-29
US20200206362A1
Human necessities

Compositions and methods for delivery of agents

 #13 | 2020-01-30
US20200032274A1
Chemistry; metallurgy

POLYNUCLEOTIDE SECONDARY STRUCTURE

 #14 | 2018-12-27 ✅ Patent 10,799,463 granted on 2020-10-13
US20180369419A1
Human necessities

Compounds and compositions for intracellular delivery of agents

 #15 | 2018-11-01
US20180311336A1
Human necessities

BROAD SPECTRUM INFLUENZA VIRUS VACCINE

 #16 | 2018-10-25
US20180303929A1
Human necessities

HERPES SIMPLEX VIRUS VACCINE

 #17 | 2018-02-08
US20180036369A1
Human necessities

COMPOSITIONS AND METHODS OF ALTERING CHOLESTEROL LEVELS

Also check out Moderna TX, Inc.'s (Cambridge, United States) applicant profile with 9 patent applications submitted.

AssigneeID:

131930 ⎘